The Swiss Rockets mission is to deliver outstanding results for patients, inventors, and investors.

Founded in 2018 in Basel, Swiss Rockets is implementing a paradigm shift in healthcare. Cancer patients will benefit from new treatment therapies developed using innovative and disruptive methods. The Swiss Rockets team combines the necessary specialist knowledge and experience to efficiently and sustainably break new ground in cancer medicine.

We aim to set new paradigms in healthcare. Disruptive innovation in everything we do will allow us to deliver breakthrough treatments to patients with cancer.
We conduct our business with the patients’ well-being in mind. Integrity, honesty, loyalty, and trust form the foundation on which we build our company and future success. All our investments, entrepreneurs, partners, and therapies always put the patients first.

Our passion for people and patients makes us go at speed and with the power of rockets.

Therapeutics

Life Sciences

Health Care

Swiss Rockets AG

Dr. Vladimir Cmiljanovic

Andreas Emmenegger

Michel Petignat

Ivana Cmiljanovic

Debora Foglia

Albert Muntane Casanova

Aurélie Jenn

Dr. Josef Künzle

Milan Crnogorac

Nadezda Gracheva

The Quality Assurance and Regulatory Affairs team at Swiss Rockets AG ensures that all innovative cancer therapies comply with national and international regulatory standards while maintaining the highest quality benchmarks. They oversee clinical trial protocols, monitor adherence to Good Clinical Practice (GCP), and drive quality improvement initiatives to safeguard patient safety and efficacy of treatments, thus supporting the mission of delivering groundbreaking healthcare solutions.

Quality Assurance and Regulatory Affairs

Leadership Team

Project Management and Operations

Quality Assurance and Regulatory Affairs

About

Team members

Other teams at Swiss Rockets AG

Leadership Team

Project Management and Operations